Literature DB >> 24366211

Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.

Heng Wang1, Qing Feng Luo2, Ai Fen Peng3, Xin Hua Long1, Tao Fang Wang1, Zhi Li Liu1, Guo Mei Zhang4, Rong Ping Zhou4, Song Gao1, Yang Zhou1, Wen Zhao Chen1.   

Abstract

The activation of PI3K/Akt and the overexpression of fatty acid synthase (FASN) are frequently observed in human osteosarcoma (OS). In the present study, in order to investigate the possible association between the phosphorylation of Akt and FASN expression, immunohistochemical staining was conducted on 24 OS specimens from patients with pulmonary metastasis, which revealed a significant positive correlation between phosphorylated Akt (p-Akt) and the expression of FASN (R=0.469, P=0.04). To investigate the association between p-Akt and FASN in vitro, human U2-OS OS cells were treated with FASN-specific RNAi plasmid or LY294002 (an inhibitor of PI3k/Akt). The mRNA levels of Akt and FASN were measured by real-time PCR. Western blot analysis was also performed to detect the protein experession of PI3K, Akt, p-Akt and FASN. The results demonstrated that the PI3K/Akt signaling pathway modulates FASN expression; the inhibition of FASN resulted in the downregulation of p-Akt in the U2-OS cells. Furthermore, the effects induced by the inhibition of the activity of p-Akt or FASN on the malignant phenotype of U2-OS cells were investigated, demonstrating that the malignant phenotype was inhibited by suppressing the activity of PI3K/Akt or FASN in the U2-OS cells. The findings from our study suggest the existence of a positive feedback regulation between Akt phosphorylation and FASN expression and that this loop may play an important role in the malignant phenotype of OS cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366211     DOI: 10.3892/ijmm.2013.1602

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  9 in total

1.  Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.

Authors:  Heidrun Karlic; Roman Thaler; Christopher Gerner; Thomas Grunt; Katharina Proestling; Florian Haider; Franz Varga
Journal:  Cancer Genet       Date:  2015-03-18

2.  LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p.

Authors:  Honghai Song; Jiaming Liu; Xin Wu; Yang Zhou; Xuanyin Chen; Jiangwei Chen; Keyu Deng; Chunxia Mao; Shanhu Huang; Zhili Liu
Journal:  Aging (Albany NY)       Date:  2019-11-13       Impact factor: 5.682

3.  Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.

Authors:  Xin Zhao; Yuying Fang; Xingwen Wang; Zhouyuan Yang; Donghai Li; Meng Tian; Pengde Kang
Journal:  Int J Oncol       Date:  2019-11-14       Impact factor: 5.650

4.  Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10.

Authors:  Jiongyu Chen; Fan Zhang; Xiaosha Ren; Yahui Wang; Wenhe Huang; Jianting Zhang; Yukun Cui
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

5.  Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma.

Authors:  Lei Yang; Fei Xie; Shuangqing Li
Journal:  Oncol Res       Date:  2016-11-08       Impact factor: 5.574

6.  Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats.

Authors:  Yujie Wang; Changyi Wu; Bin Han; Fei Xu; Mingfeng Mao; Xiangyang Guo; Jun Wang
Journal:  Mol Med Rep       Date:  2016-05-23       Impact factor: 2.952

Review 7.  Noncoding RNA in drug resistant sarcoma.

Authors:  Xiaoyang Li; Jacson K Shen; Francis J Hornicek; Tao Xiao; Zhenfeng Duan
Journal:  Oncotarget       Date:  2017-07-06

8.  TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.

Authors:  Cuiyun Li; Jing Cai; Fugui Ge; Guilong Wang
Journal:  Int J Mol Med       Date:  2018-07-04       Impact factor: 4.101

Review 9.  Fatty Acid Synthase: An Emerging Target in Cancer.

Authors:  Chee Wai Fhu; Azhar Ali
Journal:  Molecules       Date:  2020-08-28       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.